ID

17291

Beschrijving

Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00577590

Link

https://clinicaltrials.gov/show/NCT00577590

Trefwoorden

Versies (1)
  1. 04-09-16 04-09-16 -
Geüploaded op

4 september 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes Mellitus, Type II NCT00577590

Engels

Eligibility Diabetes Mellitus, Type II NCT00577590

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
meets americans with disabilities act (ada) criteria for t2dm; if newly diagnosed, must have fasting blood glucose greater than 126 mg/dl on two occasions, a random blood glucose greater than 200 mg/dl with symptoms, or a diagnostic oral glucose tolerance test
Beschrijving

American | Diabetes Mellitus, Non-Insulin-Dependent | Fasting blood glucose measurement Quantity | Random blood glucose measurement Associated with Symptoms | Oral Glucose Tolerance Test

Datatype

boolean

Alias
UMLS CUI [1]
C0596070
UMLS CUI [2]
C0011860
UMLS CUI [3,1]
C0428568
UMLS CUI [3,2]
C1265611
UMLS CUI [4,1]
C0428567
UMLS CUI [4,2]
C0332281
UMLS CUI [4,3]
C1457887
UMLS CUI [5]
C0029161
weight of less than 350 pounds
Beschrijving

Body Weight

Datatype

boolean

Alias
UMLS CUI [1]
C0005910
hemoglobin a1c of equal to or less than 7.5% at study entry or willing to go on one of the following therapies to achieve necessary percentage: metformin monotherapy greater than 1000 mg daily for at least 30 days or metformin greater than 1000 mg daily plus any combination of sulfonylurea, glipizide, or alpha-glucosidase inhibitor
Beschrijving

Glycosylated hemoglobin A | Metformin Quantity per day | Sulfonylurea | Glipizide | alpha-Glucosidase Inhibitors

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
UMLS CUI [2,1]
C0025598
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0439505
UMLS CUI [3]
C0038766
UMLS CUI [4]
C0017642
UMLS CUI [5]
C1299007
blood pressure less than 140/90 mm hg at study entry
Beschrijving

Blood Pressure

Datatype

boolean

Alias
UMLS CUI [1]
C0005823
ldl level less than 130 mg/dl if on stable lipid lowering regimen
Beschrijving

Serum LDL cholesterol measurement | Lipid-lowering therapy Stable

Datatype

boolean

Alias
UMLS CUI [1]
C0428474
UMLS CUI [2,1]
C0585943
UMLS CUI [2,2]
C0205360
willing to undergo normal rest/stress (treadmill or dobutamine) echocardiogram
Beschrijving

stress test echocardiogram at rest | Echocardiography, Stress | Treadmill Test | Dobutamine measurement

Datatype

boolean

Alias
UMLS CUI [1]
C2035956
UMLS CUI [2]
C0920208
UMLS CUI [3]
C0087110
UMLS CUI [4]
C1266511
if currently taking thyroid replacement therapy, must be on a stable dose of thyroid replacement and must have a thyroid function blood test that is in the normal range
Beschrijving

Thyroid hormone replacement therapy | Thyroid preparations Dose Stable | Thyroid function tests normal

Datatype

boolean

Alias
UMLS CUI [1]
C2242640
UMLS CUI [2,1]
C0279175
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3]
C0729749
willing to use an effective form of birth control throughout the study
Beschrijving

Contraceptive methods Willing

Datatype

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
received therapy with an insulin sensitizer of the thiazolidinedione class within 6 months prior to study entry
Beschrijving

Insulin regime | Thiazolidinediones

Datatype

boolean

Alias
UMLS CUI [1]
C0557978
UMLS CUI [2]
C1257987
required insulin therapy for more than 2 weeks in the year prior to study entry
Beschrijving

Insulin regime Duration of treatment

Datatype

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C0444921
history of angina, heart attack, coronary artery bypass grafting (cabg), stroke, congestive heart failure (chf), or peripheral vascular disease (pvd)
Beschrijving

Angina Pectoris | Myocardial Infarction | Coronary Artery Bypass Surgery | Cerebrovascular accident | Congestive heart failure | Peripheral Vascular Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0002962
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0010055
UMLS CUI [4]
C0038454
UMLS CUI [5]
C0018802
UMLS CUI [6]
C0085096
known coronary artery disease (cad) with residual lesions of greater than 50%
Beschrijving

Coronary Artery Disease | Residual Lesion Percentage

Datatype

boolean

Alias
UMLS CUI [1]
C1956346
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C1609982
UMLS CUI [2,3]
C0439165
current smoker
Beschrijving

Tobacco use

Datatype

boolean

Alias
UMLS CUI [1]
C0543414
use or expected use of corticosteroids in any form
Beschrijving

Adrenal Cortex Hormones | Adrenal Cortex Hormones Use of Expected

Datatype

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C1524063
UMLS CUI [2,3]
C1517001
serum triglycerides greater than 400 mg/dl on a fasting sample at study entry
Beschrijving

Serum Triglyceride Measurement Sample Fasting

Datatype

boolean

Alias
UMLS CUI [1,1]
C0542495
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C0015663
any contraindication to a thiazolidinedione (tzd) insulin sensitizer, metformin, or other drugs likely to be used during the study
Beschrijving

Medical contraindication Thiazolidinediones | Medical contraindication Metformin | Medical contraindication Pharmaceutical Preparations

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1257987
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0025598
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0013227
liver disease with liver function test (lft) greater than 2 times the upper limit of normal (uln)
Beschrijving

Liver disease | Liver Function Tests

Datatype

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0023901
serum creatinine greater than 1.5 mg/dl for women and 1.6 mg/dl for men or greater than 2+ proteinuria on urine dipstick
Beschrijving

Creatinine measurement, serum | Gender | Proteinuria | Urine dipstick test

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0033687
UMLS CUI [4]
C0430370
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes Mellitus, Type II NCT00577590

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
American | Diabetes Mellitus, Non-Insulin-Dependent | Fasting blood glucose measurement Quantity | Random blood glucose measurement Associated with Symptoms | Oral Glucose Tolerance Test
Item
meets americans with disabilities act (ada) criteria for t2dm; if newly diagnosed, must have fasting blood glucose greater than 126 mg/dl on two occasions, a random blood glucose greater than 200 mg/dl with symptoms, or a diagnostic oral glucose tolerance test
boolean
C0596070 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0428568 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0428567 (UMLS CUI [4,1])
C0332281 (UMLS CUI [4,2])
C1457887 (UMLS CUI [4,3])
C0029161 (UMLS CUI [5])
Body Weight
Item
weight of less than 350 pounds
boolean
C0005910 (UMLS CUI [1])
Glycosylated hemoglobin A | Metformin Quantity per day | Sulfonylurea | Glipizide | alpha-Glucosidase Inhibitors
Item
hemoglobin a1c of equal to or less than 7.5% at study entry or willing to go on one of the following therapies to achieve necessary percentage: metformin monotherapy greater than 1000 mg daily for at least 30 days or metformin greater than 1000 mg daily plus any combination of sulfonylurea, glipizide, or alpha-glucosidase inhibitor
boolean
C0019018 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439505 (UMLS CUI [2,3])
C0038766 (UMLS CUI [3])
C0017642 (UMLS CUI [4])
C1299007 (UMLS CUI [5])
Blood Pressure
Item
blood pressure less than 140/90 mm hg at study entry
boolean
C0005823 (UMLS CUI [1])
Serum LDL cholesterol measurement | Lipid-lowering therapy Stable
Item
ldl level less than 130 mg/dl if on stable lipid lowering regimen
boolean
C0428474 (UMLS CUI [1])
C0585943 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
stress test echocardiogram at rest | Echocardiography, Stress | Treadmill Test | Dobutamine measurement
Item
willing to undergo normal rest/stress (treadmill or dobutamine) echocardiogram
boolean
C2035956 (UMLS CUI [1])
C0920208 (UMLS CUI [2])
C0087110 (UMLS CUI [3])
C1266511 (UMLS CUI [4])
Thyroid hormone replacement therapy | Thyroid preparations Dose Stable | Thyroid function tests normal
Item
if currently taking thyroid replacement therapy, must be on a stable dose of thyroid replacement and must have a thyroid function blood test that is in the normal range
boolean
C2242640 (UMLS CUI [1])
C0279175 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0729749 (UMLS CUI [3])
Contraceptive methods Willing
Item
willing to use an effective form of birth control throughout the study
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Insulin regime | Thiazolidinediones
Item
received therapy with an insulin sensitizer of the thiazolidinedione class within 6 months prior to study entry
boolean
C0557978 (UMLS CUI [1])
C1257987 (UMLS CUI [2])
Insulin regime Duration of treatment
Item
required insulin therapy for more than 2 weeks in the year prior to study entry
boolean
C0557978 (UMLS CUI [1,1])
C0444921 (UMLS CUI [1,2])
Angina Pectoris | Myocardial Infarction | Coronary Artery Bypass Surgery | Cerebrovascular accident | Congestive heart failure | Peripheral Vascular Disease
Item
history of angina, heart attack, coronary artery bypass grafting (cabg), stroke, congestive heart failure (chf), or peripheral vascular disease (pvd)
boolean
C0002962 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0018802 (UMLS CUI [5])
C0085096 (UMLS CUI [6])
Coronary Artery Disease | Residual Lesion Percentage
Item
known coronary artery disease (cad) with residual lesions of greater than 50%
boolean
C1956346 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C1609982 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Tobacco use
Item
current smoker
boolean
C0543414 (UMLS CUI [1])
Adrenal Cortex Hormones | Adrenal Cortex Hormones Use of Expected
Item
use or expected use of corticosteroids in any form
boolean
C0001617 (UMLS CUI [1])
C0001617 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C1517001 (UMLS CUI [2,3])
Serum Triglyceride Measurement Sample Fasting
Item
serum triglycerides greater than 400 mg/dl on a fasting sample at study entry
boolean
C0542495 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C0015663 (UMLS CUI [1,3])
Medical contraindication Thiazolidinediones | Medical contraindication Metformin | Medical contraindication Pharmaceutical Preparations
Item
any contraindication to a thiazolidinedione (tzd) insulin sensitizer, metformin, or other drugs likely to be used during the study
boolean
C1301624 (UMLS CUI [1,1])
C1257987 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
Liver disease | Liver Function Tests
Item
liver disease with liver function test (lft) greater than 2 times the upper limit of normal (uln)
boolean
C0023895 (UMLS CUI [1])
C0023901 (UMLS CUI [2])
Creatinine measurement, serum | Gender | Proteinuria | Urine dipstick test
Item
serum creatinine greater than 1.5 mg/dl for women and 1.6 mg/dl for men or greater than 2+ proteinuria on urine dipstick
boolean
C0201976 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0033687 (UMLS CUI [3])
C0430370 (UMLS CUI [4])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial